Absolute Return Capital’s Boston Scientific BSX Stock Holding History

Absolute Return Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-34,618	Closed	-$459K	–	598
2014 Q4	$459K	Sell	34,618 -376,863	-92%	-$4.82M	0.01%	535
2014 Q3	$4.86M	Buy	+411,481	New	+$5.18M	0.07%	303
2014 Q1	–	Sell	-924,381	Closed	-$11.1M	–	1236
2013 Q4	$11.1M	Sell	924,381 -337,875	-27%	-$3.99M	0.12%	223
2013 Q3	$14.8M	Sell	1,262,256 -1,957,372	-61%	-$21.2M	0.21%	147
2013 Q2	$29.8M	Buy	+3,219,628	New	+$27.3M	0.38%	72

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Absolute Return Capital's BSX Position: Q1 2015 in Review

Absolute Return Capital sold out of Boston Scientific (BSX) in Q1 2015, closing a stake of 34,618 shares — an estimated $459K sold.

Absolute Return Capital first reported a position in BSX in Q2 2013 and held it in 5 quarters. The position peaked at $29.8M in Q2 2013. 471 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

Absolute Return Capital reported no remaining Boston Scientific position as of Q1 2015 after selling out during the quarter.
Absolute Return Capital sold 34,618 Boston Scientific shares in Q1 2015, an estimated $459K.
Absolute Return Capital first reported a position in Boston Scientific in Q2 2013 and held it in 5 quarters.
Absolute Return Capital's Boston Scientific position peaked at $29.8M in Q2 2013.
471 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on Absolute Return Capital's 13F filing for Q1 2015, filed 15 May 2015.